[1]
|
Mahle, W.T. (2008) Cardiac retransplantation in children. Pediatric Transplantation, 12, 274-280.
doi:10.1111/j.1399-3046.2007.00854.x
|
[2]
|
Sacks, J.H., Mahle, W., Abramowsky, C.R., Steelman, C.K., Kanter, K.R., Vincent, R.N., Berg, A. and Shehata B. (2010) Fibrofatty changes in failed pediatric cardiac allografts. Pediatric and Developmental Pathology, 14, 194-197.
|
[3]
|
Milanesi, O., Cerutti, A., Biffanti, R., Salvadori, S., Gambino, A. and Stellin, G. (2007) Heart transplantation in pediatric age. Journal of Cardiovascular Medicine, 8, 67-71. doi:10.2459/01.JCM.0000247439.89946.20
|
[4]
|
Huebler, M., Schubert, S., Lehmkuhl, H.B., Weng, Y., Miera, O., Alexi-Meskishvili, V., Berger and F., Hetzer, R. (2011) Pediatric heart transplantation: 23-year single-center experience. European Journal Cardio—Thoracic Surgery, 39, e83-e89. doi:10.1016/j.ejcts.2010.12.067
|
[5]
|
Perens, G., Li, F., Meier, S., Kaur, R., Alejos, J.C. and Fishbein, M. (2009) Clinico-pathologic findings in end-stage pediatric heart transplant grafts. Pediatric Transplantation, 13, 887-891.
doi:10.1111/j.1399-3046.2008.01087.x
|
[6]
|
Hollenberg, S.M., Klein, L.W., Parrillo, J.E., Scherer, M., Burns, D., Tamburro, P., Oberoi, M., Johnson, M.R. and Costanzo, M.R. (2001) Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation, 104, 3091-3096.
doi:10.1161/hc5001.100796
|
[7]
|
Khan, U.A., Williams, S.G., Fildes, J.E. and Shaw, S.M. (2009) The pathophysiology of chronic graft failure in the cardiac transplant patient. American Journal of Transplantation, 9, 2211-2216.
doi:10.1111/j.1600-6143.2009.02807.x
|
[8]
|
Krenning, G., Zeisberg, E.M. and Kalluri R. (2010) The origin of fibroblasts and mechanism of cardiac fibrosis. Journal of Cellular Physiology, 225, 631-637.
doi:10.1002/jcp.22322
|
[9]
|
Gandhi, M.S., Kamalov, G., Shahbaz, A.U., Bhattacharya, S.K., Ahokas, R.A., Sun, Y., Gerling, I.C. and Weber, K.T. (2011) Cellular and molecular pathways to myocardial necrosis and replacement fibrosis. Heart Failure Reviews, 16, 23-34. doi:10.1007/s10741-010-9169-3
|
[10]
|
Mehra, M.R., Uber, P.A. and Benitez, R.M. (2010) Gene-based bio-signature patterns and cardiac allograft rejection. Heart Failure Clinics, 6, 87-92.
doi:10.1016/j.hfc.2009.08.010
|
[11]
|
Di Filippo, S., Girnita, A., Webber, S.A., Tsao, S., Boyle, G.J., Miller, S.A., Gandhi, S.K. and Zeevi, A. (2005) Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Human Immunology, 66, 513-518. doi:10.1016/j.humimm.2004.12.008
|
[12]
|
LaRosa, C., Baluarte, H.J. and Meyers, K.E. (2011) Outcomes in pediatric solid-organ transplantation. Pediatric Transplantation, 15, 128-141.
doi:10.1111/j.1399-3046.2010.01434.x
|
[13]
|
Moulik, M., Breinholt, J.P., Dreyer, W.J., et al. (2010) Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients. Journal of the American College of Cardiology, 56, 582-592. doi:10.1016/j.jacc.2010.02.060
|
[14]
|
Tambur, A.R., Pamboukian, S., Costanzo, M.R. and Heroux, A. (2006) Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation, 25, 690-698. doi:10.1016/j.healun.2006.02.006
|
[15]
|
Ternstrom, L., Jeppsson, A., Ricksten, A. and Nilsson, F. (2005) Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation, 24, 433-438.
doi:10.1016/j.healun.2004.02.019
|